Last reviewed · How we verify
Cupric Sulfate (copper sulfate)
At a glance
| Generic name | copper sulfate |
|---|---|
| Sponsor | Abraxis Pharm |
| Drug class | copper sulfate |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 1987 |
Approved indications
Common side effects
Key clinical trials
- Coordinated Emergency Department Transitions (NA)
- The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age (NA)
- Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety (PHASE4)
- Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia
- Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN (PHASE4)
- Prenatal Iodine Supplementation and Early Childhood Neurodevelopment (PHASE4)
- Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia (PHASE2,PHASE3)
- Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients (PHASE2)
Patents
| Patent | Expiry | Type |
|---|---|---|
| 10398588 | 2034-02-24 | Formulation |
| 9610191 | 2034-02-24 | Method of Use |
| 9265652 | 2034-04-28 | Method of Use |
| 9427351 | 2032-08-14 | Formulation |
| 11850181 | 2032-08-14 | Formulation |
| 10918516 | 2037-01-23 | Formulation |
| 10188546 | 2032-08-14 | Formulation |
| 11207209 | 2034-08-16 | Formulation |
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cupric Sulfate CI brief — competitive landscape report
- Cupric Sulfate updates RSS · CI watch RSS
- Abraxis Pharm portfolio CI